Find a Trial

Trial Summary


Protocol No.2018-0877
StatusOPEN TO ACCRUAL
Principal InvestigatorTurk, Anita
ScopeNational
PhasePhase II
Age GroupAdult
TitlePhase II Study of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Previously Treated Advanced Biliary Tract Cancer (NAPOLI-2)
DescriptionThis is a study to evaluate the clinical activity of the combination of fluorouracil, leucovorin, and nanoliposomal irinotecan as second-line treatment in patients with advanced biliary tract cancers following gemcitabine and platinum chemotherapy.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:
  • Pathologically-confirmed biliary tract cancer (cholangiocarcinoma or gallbladder adenocarcinoma), unresectable or metastatic.
  • No more than 1 prior line of chemotherapy for unresectable or metastatic disease (adjuvant therapy does not count).
For a full list of participation criteria, please visit clinicaltrials.gov.
Applicable Disease SitesLiver
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu